{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:39:07Z","timestamp":1791545947862,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:00:00Z","timestamp":1557532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Investigator Initiated Trial Grant, Allergan","award":["IIT-2017-10168"],"award-info":[{"award-number":["IIT-2017-10168"]}]},{"name":"The Hospital Research Foundation Grant","award":["Basil Hetzel Research Institute, Queen Elizabeth Foundation"],"award-info":[{"award-number":["Basil Hetzel Research Institute, Queen Elizabeth Foundation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1325-3","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T14:58:58Z","timestamp":1557586738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study"],"prefix":"10.1186","volume":"19","author":[{"given":"Anupam","family":"Datta Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Visvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Koblar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,11]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/brain\/aws146","volume":"135","author":"CM Stinear","year":"2012","unstructured":"Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012;135:2527\u201335.","journal-title":"Brain"},{"key":"1325_CR2","unstructured":"https:\/\/www.safetyandquality.gov.au\/wp-content\/uploads\/2012\/01\/National-Goals-consultation-Submission-76-National-Stroke-Foundation-17-Feb-2012.pdf\n                    \n                   stats."},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1474-4422(09)70150-4","volume":"8","author":"P Langhorne","year":"2009","unstructured":"Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741\u201354.","journal-title":"Lancet Neurol"},{"issue":"Suppl 2","key":"1325_CR4","first-page":"S27","volume":"80","author":"RD Zorowitz","year":"2013","unstructured":"Zorowitz RD, Gillard PJ, Brainin M. Poststroke spasticity-sequelae and burden on stroke survivors and caregivers. Neurology. 2013;80(Suppl 2):S27\u201334.","journal-title":"Neurology"},{"key":"1325_CR5","unstructured":"Sunnerhagen KS, Olver J, Francisco GE. Assessing and treating functional impairment in post-stroke spasticity. Neurology. 2013(Suppl 2):80, S35\u2013S44."},{"key":"1325_CR6","unstructured":"Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. Miami: year book medical: Publishers; 1980. p. 485\u201394."},{"key":"1325_CR7","unstructured":"Stroke Smart. Spasticity: how to tone it down after a stroke. \n                    http:\/\/www.strokesmart.org\/article%3Fid%3D120\n                    \n                  . Accessed 10 Mar 2017."},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/864835","volume":"2012","author":"B Langhammer","year":"2012","unstructured":"Langhammer B, Lindmark B. Functional exercise and physical fitness post stroke: the importance of exercise maintenance for motor control and physical fitness after stroke. Stroke Res Treat. 2012;2012:1\u20139.","journal-title":"Stroke Res Treat"},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2013.00887","volume":"7","author":"R Nudo","year":"2013","unstructured":"Nudo R. Recovery after brain injury: mechanisms and principles. Front Human Neurosci. 2013;7:1\u201314.","journal-title":"Front Human Neurosci"},{"issue":"s1","key":"1325_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1046\/j.1468-1331.2002.0090s1042.x","volume":"9","author":"A. P. Moore","year":"2002","unstructured":"Moore AP. Botulinum toxin (BoNT-A) for spasticity in adults. What is the evidence? Eur J Neurol. 2002; 9 Suppl 1:42\u20137:53\u201361.","journal-title":"European Journal of Neurology"},{"issue":"2","key":"1325_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1310\/tsr1902-115","volume":"19","author":"R Teasell","year":"2012","unstructured":"Teasell R, Foley N, Pereira S, Sequeira K, et al. Evidence to practice: outline toxin in the treatment of spasticity post stroke. Stroke Rehab. 2012;19(2):115\u201321.","journal-title":"Stroke Rehab"},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-017-0670-9","volume":"7","author":"AD Gupta","year":"2018","unstructured":"Gupta AD, Chu WH, Howell S, Chakrabarty S, Koblar S, Visvanathan R, Cameron I, Wilson D. Efficacy of botulinum toxin on walking and quality of life in post-stroke lower limb spasticity. Syst Rev. 2018;7:1\u20139.","journal-title":"Syst Rev"},{"issue":"3","key":"1325_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp.61.3.265","volume":"61","author":"P Burbaud","year":"1996","unstructured":"Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):265\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1325_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000069495","volume":"15","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, et al. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type a (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003;15(4):289\u2013300.","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"1325_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.apmr.2003.08.081","volume":"85","author":"CA Johnson","year":"2004","unstructured":"Johnson CA, et al. The effect of combined use of botulinum toxin type a and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Arch Phys Med Rehabil. 2004;85(6):902\u20139.","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"1325_CR16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00415-010-5526-3","volume":"257","author":"R Kaji","year":"2010","unstructured":"Kaji R, et al. Botulinum toxin type a in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol. 2010;257(8):1330\u20137.","journal-title":"J Neurol"},{"issue":"3","key":"1325_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1589\/jpts.27.759","volume":"27","author":"Wu Tao","year":"2015","unstructured":"Tao, W., et al. (2015). Gait improvement by low-dose botulinum toxin A injection treatment of the lower limbs in subacute stroke patients. Journal of Physical Therapy Science 2014; 27(3): 759\u2013762.","journal-title":"Journal of Physical Therapy Science"},{"issue":"1","key":"1325_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1682\/JRRD.2003.11.0171","volume":"42","author":"M Kosak","year":"2005","unstructured":"Kosak M, Smith T. Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke. J of Rehabil Res Dev. 2005;42(1):103\u20138.","journal-title":"J of Rehabil Res Dev"},{"issue":"7","key":"1325_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1177\/1545968315613862","volume":"30","author":"JC Singer","year":"2016","unstructured":"Singer JC, Nishihara K, Mochizuki G. Does Poststroke lower-limb spasticity influence the recovery of standing balance control? A 2-year multilevel growth model. Neurorehabil Neural Rep. 2016;30(7):626\u201334.","journal-title":"Neurorehabil Neural Rep"},{"issue":"3","key":"1325_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1310\/tsr2103-197","volume":"21","author":"TB Hafsteinsd\u00f3ttir","year":"2014","unstructured":"Hafsteinsd\u00f3ttir TB, Rensink M, Schuurmans M. Clinimetric properties of the timed up and go test for patients with stroke: a systematic review. Top Stroke Rehabil. 2014;21(3):197\u2013210.","journal-title":"Top Stroke Rehabil"},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1161\/STROKEAHA.108.516153","volume":"39","author":"GD Caty","year":"2008","unstructured":"Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008;39:2803\u20138.","journal-title":"Stroke"},{"issue":"19","key":"1325_CR22","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3109\/09638288.2015.1107781","volume":"38","author":"D Mullins","year":"2016","unstructured":"Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE. Frequency and characteristics of goal attainment following BoNTA injection for management of spasticity. Disabil Rehabil. 2016;38(19):1927\u201333.","journal-title":"Disabil Rehabil"},{"issue":"2","key":"1325_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147980","volume":"11","author":"K Wales","year":"2016","unstructured":"Wales K, Clemson L, Lannin N, Cameron I. Functional assessments used by occupational therapists with older adults at risk of activity and participation limitations: a systematic review. PLoS One. 2016;11(2):e0147980. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147980\n                    \n                  .","journal-title":"PLoS One"},{"key":"1325_CR24","unstructured":"http:\/\/www.ANZCTR.org.au\/ACTRN12617001603303.aspx\n                    \n                  ."},{"key":"1325_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/STROKEAHA.108.523621","volume":"40","author":"D Rand","year":"2009","unstructured":"Rand D, Eng JJ, Tang P, Jeng J, Hung C. How active are people with stroke? Use of Accelerometersto assess physical activity. Stroke. 2009;40:163\u20138.","journal-title":"Stroke"},{"key":"1325_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.apmr.2006.02.015","volume":"87","author":"C Turkel","year":"2006","unstructured":"Turkel C, et al. Pooled analysis of the safety of botulinum toxin type a in the treatment of poststroke spasticity. Arch Phys Med Rehabil. 2006;87:786\u201392.","journal-title":"Arch Phys Med Rehabil"},{"key":"1325_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J. Safety of botulinum toxin type a: a systematic review and meta-analysis. Curr Med Res Opin. 2004;20:981\u201390.","journal-title":"Curr Med Res Opin"},{"key":"1325_CR28","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","volume":"31","author":"AM Bakheit","year":"2000","unstructured":"Bakheit AM, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type a (Dysport) with placebo in upper limb spasticity after stroke. Stroke. 2000;31:2402\u20136.","journal-title":"Stroke"},{"issue":"5","key":"1325_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNF.0b013e3181f5329e","volume":"33","author":"B Crowner","year":"2010","unstructured":"Crowner B, et al. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clin Neuropharmacol. 2010;33(5):243\u20137.","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 1","key":"1325_CR30","first-page":"36","volume":"79","author":"D Dressler","year":"2008","unstructured":"Dressler D. Clinical relevance of botulinum toxin antibodies. Nervenarzt. 2008;79(Suppl 1):36\u201340.","journal-title":"Nervenarzt"},{"key":"1325_CR31","first-page":"56","volume-title":"Research methods for clinical and Health Psychology","author":"H Joffe","year":"2004","unstructured":"Joffe H, Yardley L. Content and thematic analysis. In: Marks DF, Yardley L, editors. Research methods for clinical and Health Psychology. London: Sage Publications Ltd; 2004. p. 56\u201368."},{"key":"1325_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1325_CR33","first-page":"1408","volume":"20","author":"PI Fusch","year":"2015","unstructured":"Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. Qual Rep. 2015;20:1408\u201316.","journal-title":"Qual Rep"},{"issue":"2","key":"1325_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00004356-198806000-00012","volume":"11","author":"RW Bohannon","year":"1988","unstructured":"Bohannon RW, Andrews AW, Smith MB. Rehabilitation goals of patients with hemiplegia. Int J Rehabil Res. 1988;11(2):181\u20133.","journal-title":"Int J Rehabil Res"},{"key":"1325_CR35","first-page":"1","volume":"12","author":"A Esquenazi","year":"2004","unstructured":"Esquenazi A. Falls and fractures in older post-stroke patients with spasticity: consequences and drug treatment considerations. Clin Geriatr. 2004;12:1\u20139.","journal-title":"Clin Geriatr"},{"key":"1325_CR36","first-page":"607","volume":"18","author":"A Esquenazi","year":"2011","unstructured":"Esquenazi A. The human and economic burden of post stroke spasticity and muscle Overactivity. JClin Outcome Management. 2011;18:607\u201314.","journal-title":"JClin Outcome Management"},{"issue":"2","key":"1325_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/ageing\/13.2.76","volume":"13","author":"DT Wade","year":"1984","unstructured":"Wade DT, Skilbeck CE, Wood VA, Langton Hewer R. Long-term survival after stroke. Age Ageing. 1984;13(2):76\u201382.","journal-title":"Age Ageing"},{"issue":"17","key":"1325_CR38","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.295.17.2018","volume":"295","author":"AB Newman","year":"2006","unstructured":"Newman AB, Simonsick EM, Naydeck BL, et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA. 2006;295(17):2018\u20136.","journal-title":"JAMA."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1325-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T23:04:55Z","timestamp":1589065495000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1325-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1325-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,11]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Hospital Research Ethics Committee has approved the study and all the participants will provide written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no financial or non-financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"96"}}